| Name | Title | Contact Details |
|---|
Oasis Healthcare Limited, through its subsidiaries, provides NHS and private dental care services in the United Kingdom. It offers NHS dentistry services, private dentistry services, and implants. It also offers treatments in the areas of bridges, crowns, dentures, fillings, inlays and onlays, fillings, gum diseases, root canal, teeth straightening, teeth whitening, temporo-mandibular joint dysfunction, and veneers. Oasis Healthcare Limited was founded in 1996 and is based in Bristol, United Kingdom.
Cricket Health is a specialty kidney care provider of integrated nephrology and dialysis care for people with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD). Cricket Health delivers world-class, technology-enabled multidisciplinary care both in-person and virtually to achieve the best outcomes possible for patients and the best value for partners, keeping patients healthy and out of the hospital, accelerating access to transplant, and increasing home dialysis adoption. We are committed to aligning the success of our company with those of our partners and the patients whom we serve.
American Hospital Service Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Care Access Health Plan is a Hallandale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.